Delayed Access to Securities Firms' MTS Due to SK Bioscience
[Asia Economy Reporter Song Hwajeong] On the second day of SK Bioscience's listing, heavy trading caused access disruptions to the mobile trading systems (MTS) and home trading systems (HTS) of various securities firms.
According to the financial investment industry on the 19th, since the market opened, Mirae Asset Daewoo's MTS has been inaccessible. Investors are experiencing inconvenience due to errors such as delayed login or the MTS not opening at all and becoming unresponsive.
A Mirae Asset Daewoo official said, "There is a delay in access after the market opened," adding, "We are currently assessing the situation."
NH Investment & Securities' MTS also experienced slight delays in access and trading immediately after the market opened among some investors. NH Investment & Securities announced, "Due to a surge in order volume for SK Bioscience and others, there is a delay in reflecting order details and transaction confirmations." An NH Investment & Securities representative stated, "It was not an access delay issue but only a slight delay in transaction confirmation," and added, "No complaints have been received."
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- SungSook Han: “Linking Support for Small Business Owners During Suspension or Closure With Psychological Recovery Systems”
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
These access delays at securities firms are presumed to be caused by system overload as many SK Bioscience investors engaged in heavy trading. SK Bioscience failed to achieve ‘ttasangssang’ (opening price doubling followed by two consecutive days of upper limit price), leading to a significant increase in sell orders. As of 10:10 a.m. that day, the trading volume reached 7.7 million shares, a substantial increase from the previous day's mere 870,000 shares.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.